AFMD Affimed N.V.

2.25
0  -4%
Previous Close 2.35
Open 2.25
Price To book 1.90
Market Cap 98.86M
Shares 43,938,000
Volume 644,044
Short Ratio 1.93
Av. Daily Volume 291,003

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1b update 2H 2017.
AFM13
Hodgkin Lymphoma - Cancer
Phase 2a trial to be initiated 1H 2017 with an update due 2H 2017.
AFM13
Hodgkin Lymphoma - Cancer